Roubertoux PL, Carlier M (2010) Mouse models of cognitive disabilities in trisomy 21 (Down syndrome). Am J Med Genet C Semin Med Genet 154C:400–416. doi:10.1002/ajmg.c.30280 ArticlePubMed Google Scholar
Holtzman DM, Santucci D, Kilbridge J et al (1996) Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc Natl Acad Sci USA 93:13333–13338 ArticleCASPubMed CentralPubMed Google Scholar
Costa AC, Walsh K, Davisson MT (1999) Motor dysfunction in a mouse model for Down syndrome. Physiol Behav 68:211–220 ArticleCASPubMed Google Scholar
Escorihuela RM, Fernández-Teruel A, Vallina IF et al (1995) A behavioral assessment of Ts65Dn mice: a putative Down syndrome model. Neurosci Lett 199:143–146 ArticleCASPubMed Google Scholar
Escorihuela RM, Vallina IF, Martínez-Cué C et al (1998) Impaired short- and long-term memory in Ts65Dn mice, a model for down syndrome. Neurosci Lett 247:171–174 ArticleCASPubMed Google Scholar
Demas GE, Nelson RJ, Krueger BK, Yarowsky PJ (1998) Impaired spatial working and reference memory in segmental trisomy (Ts65Dn) mice. Behav Brain Res 90:199–201 ArticleCASPubMed Google Scholar
Demas GE, Nelson RJ, Krueger BK, Yarowsky PJ (1999) Spatial memory deficits in segmental trisomic Ts65Dn mice. Behav Brain Res 82:85–92 Article Google Scholar
Hyde LA, Frisone DF, Crnic LS (2001) Ts65Dn mice, a model for Down syndrome, have deficits in context discrimination learning suggesting impaired hippocampal function. Behav Brain Res 118:53–60 ArticleCASPubMed Google Scholar
Siarey RJ, Stoll J, Rapoport SI, Galdzicki Z (1997) Altered long-term potentiation in the young and old Ts65Dn mouse, a model for down Syndrome. Neuropharmacology 36:1549–1554 ArticleCASPubMed Google Scholar
Kleschevnikov AM, Belichenko PV, Villar AJ et al (2004) Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J Neurosci 24:8153–8160. doi:10.1523/JNEUROSCI.1766-04.2004 ArticleCASPubMed Google Scholar
Siarey RJ, Carlson EJ, Epstein CJ et al (1999) Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome. Neuropharmacology 38:1917–1920 ArticleCASPubMed Google Scholar
Insausti AM, Megías M, Crespo D et al (1998) Hippocampal volume and neuronal number in Ts65Dn mice: a murine model of Down syndrome. Neurosci Lett 253:175–178 ArticleCASPubMed Google Scholar
Masliah E, Terry RD, Alford M, DeTeresa R (1990) Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections. J Histochem Cytochem 38:837–844 ArticleCASPubMed Google Scholar
Eastwood SL, Harrison PJ (2001) Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Res Bull 55:569–578 ArticleCASPubMed Google Scholar
Belichenko NP, Belichenko PV, Kleschevnikov AM et al (2009) The “Down syndrome critical region” is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of down syndrome. J Neurosci 29:5938–5948. doi:10.1523/JNEUROSCI.1547-09.2009 ArticleCASPubMed CentralPubMed Google Scholar
Belichenko PV, Masliah E, Kleschevnikov AM et al (2004) Synaptic structural abnormalities in the Ts65Dn mouse model of down syndrome. J Comp Neurol 480:281–298. doi:10.1002/cne.20337 ArticlePubMed Google Scholar
Belichenko PV, Kleschevnikov AM, Salehi A et al (2007) Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships. J Comp Neurol 504:329–345. doi:10.1002/cne.21433 ArticleCASPubMed Google Scholar
Pérez-Cremades D, Hernández S, Blasco-Ibáñez JM et al (2010) Alteration of inhibitory circuits in the somatosensory cortex of Ts65Dn mice, a model for Down’s syndrome. J Neural Transm 117:445–455. doi:10.1007/s00702-010-0376-9 ArticlePubMed Google Scholar
Kurt MA, Davies DC, Kidd M et al (2000) Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice. Brain Res 858:191–197 ArticleCASPubMed Google Scholar
Fernandez F, Morishita W, Zuniga E et al (2007) Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat Neurosci 10:411–413. doi:10.1038/nn1860 CASPubMed Google Scholar
Rubenstein JLR, Merzenich MM (2003) Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2:255–267 ArticleCASPubMed Google Scholar
Zold CL, Larramendy C, Riquelme LA, Murer MG (2007) Distinct changes in evoked and resting globus pallidus activity in early and late Parkinson’s disease experimental models. Eur J Neurosci 26:1267–1279. doi:10.1111/j.1460-9568.2007.05754.x ArticlePubMed Google Scholar
Reynolds GP, Warner CE (1988) Amino acid neurotransmitter deficits in adult Down’s syndrome brain tissue. Neurosci Lett 94:224–227 ArticleCASPubMed Google Scholar
Risser D, Lubec G, Cairns N, Herrera-Marschitz M (1997) Excitatory amino acids and monoamines in parahippocampal gyrus and frontal cortical pole of adults with Down syndrome. Life Sci 60:1231–1237 ArticleCASPubMed Google Scholar
Hernández S, Gilabert-Juan J, Blasco-Ibáñez JM et al (2012) Altered expression of neuropeptides in the primary somatosensory cortex of the Down syndrome model Ts65Dn. Neuropeptides 46:29–37. doi:10.1016/j.npep.2011.10.002 ArticlePubMed Google Scholar
Hunter CL, Bachman D, Granholm A-C (2004) Minocycline prevents cholinergic loss in a mouse model of Down’s syndrome. Ann Neurol 56:675–688. doi:10.1002/ana.20250 ArticleCASPubMed Google Scholar
Liu DP, Schmidt C, Billings T, Davisson MT (2003) Quantitative PCR genotyping assay for the Ts65Dn mouse model of Down syndrome. Biotechniques 35:1170–4, 1176, 1178 passim
Lantos TA, Görcs TJ, Palkovits M (1995) Immunohistochemical mapping of neuropeptides in the premamillary region of the hypothalamus in rats. Brain Res Brain Res Rev 20:209–249 ArticleCASPubMed Google Scholar
Csiffáry A, Görcs TJ, Palkovits M (1990) Neuropeptide Y innervation of ACTH-immunoreactive neurons in the arcuate nucleus of rats: a correlated light and electron microscopic double immunolabeling study. Brain Res 506:215–222 ArticlePubMed Google Scholar
Varea E, Blasco-Ibáñez JM, Gómez-Climent MA et al (2007) Chronic fluoxetine treatment increases the expression of PSA-NCAM in the medial prefrontal cortex. Neuropsychopharmacology 32:803–812. doi:10.1038/sj.npp.1301183 ArticleCASPubMed Google Scholar
Nacher J, Alonso-Llosa G, Rosell D, McEwen B (2002) PSA-NCAM expression in the piriform cortex of the adult rat. Modulation by NMDA receptor antagonist administration. Brain Res 927:111–121 ArticleCASPubMed Google Scholar
Gundersen HJ, Jensen EB (1987) The efficiency of systematic sampling in stereology and its prediction. J Microsc 147:229–263 ArticleCASPubMed Google Scholar
Földy C, Aradi I, Howard A, Soltesz I (2004) Diversity beyond variance: modulation of firing rates and network coherence by GABAergic subpopulations. Eur J Neurosci 19:119–130 ArticlePubMed Google Scholar
Howell MD, Gottschall PE (2012) Altered synaptic marker abundance in the hippocampal stratum oriens of Ts65Dn mice is associated with exuberant expression of versican. ASN Neuro. doi:10.1042/AN20110037
Begenisic T, Spolidoro M, Braschi C et al (2011) Environmental enrichment decreases GABAergic inhibition and improves cognitive abilities, synaptic plasticity, and visual functions in a mouse model of Down syndrome. Front Cell Neurosci 5:29. doi:10.3389/fncel.2011.00029 ArticleCASPubMed CentralPubMed Google Scholar
Rueda N, Llorens-Martín M, Flórez J et al (2010) Memantine normalizes several phenotypic features in the Ts65Dn mouse model of Down syndrome. J Alzheimers Dis 21:277–290. doi:10.3233/JAD-2010-100240 CASPubMed Google Scholar
Popov VI, Kleschevnikov AM, Klimenko OA et al (2011) Three-dimensional synaptic ultrastructure in the dentate gyrus and hippocampal area CA3 in the Ts65Dn mouse model of Down syndrome. J Comp Neurol 519:1338–1354. doi:10.1002/cne.22573 ArticleCASPubMed Google Scholar
Whittle N, Sartori SB, Dierssen M et al (2007) Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development. Pediatrics 120:e1465–e1471. doi:10.1542/peds.2006-3448 ArticlePubMed Google Scholar
Seidl R, Cairns N, Singewald N et al (2001) Differences between GABA levels in Alzheimer’s disease and Down syndrome with Alzheimer-like neuropathology. Naunyn Schmiedebergs Arch Pharmacol 363:139–145 ArticleCASPubMed Google Scholar
Acsády L, Görcs TJ, Freund TF (1996) Different populations of vasoactive intestinal polypeptide-immunoreactive interneurons are specialized to control pyramidal cells or interneurons in the hippocampus. Neuroscience 73:317–334 ArticlePubMed Google Scholar
Blasco-Ibáñez JM, Martínez-Guijarro FJ, Freund TF (1998) Enkephalin-containing interneurons are specialized to innervate other interneurons in the hippocampal CA1 region of the rat and guinea-pig. Eur J Neurosci 10:1784–1795 ArticlePubMed Google Scholar
Stafstrom CE (1993) Epilepsy in Down syndrome: clinical aspects and possible mechanisms. Am J Ment Retard 98(Suppl):12–26 PubMed Google Scholar
Blümcke I, Suter B, Behle K et al (2000) Loss of hilar mossy cells in Ammon’s horn sclerosis. Epilepsia 41(Suppl 6):S174–S180 ArticlePubMed Google Scholar
Caserta MT (1994) Neuropeptide Y immunoreactive neurons in murine trisomy 16 cortical cultures. Plasticity of expression and differentiation. Mol Chem Neuropathol 22:197–210 ArticleCASPubMed Google Scholar
Hill JM, Ades AM, McCune SK et al (2003) Vasoactive intestinal peptide in the brain of a mouse model for Down syndrome. Exp Neurol 183:56–65 ArticleCASPubMed Google Scholar
Sahir N, Brenneman DE, Hill JM (2006) Neonatal mice of the Down syndrome model, Ts65Dn, exhibit upregulated VIP measures and reduced responsiveness of cortical astrocytes to VIP stimulation. J Mol Neurosci 30:329–340. doi:10.1385/JMN:30:3:329 ArticleCASPubMed Google Scholar
Ross MH, Galaburda AM, Kemper TL (1984) Down’s syndrome: is there a decreased population of neurons? Neurology 34:909–916 ArticleCASPubMed Google Scholar
Kobayashi K, Emson PC, Mountjoy CQ et al (1990) Cerebral cortical calbindin D28K and parvalbumin neurones in Down’s syndrome. Neurosci Lett 113:17–22 ArticleCASPubMed Google Scholar
Pueschel SM, Louis S, McKnight P (1991) Seizure disorders in Down syndrome. Arch Neurol 48:318–320 ArticleCASPubMed Google Scholar
Prasher VP (1995) Epilepsy and associated effects on adaptive behaviour in adults with Down syndrome. Seizure 4:53–56 ArticleCASPubMed Google Scholar
Johannsen P, Christensen JE, Goldstein H et al (1996) Epilepsy in Down syndrome–prevalence in three age groups. Seizure 5:121–125 CASPubMed Google Scholar
Goldberg-Stern H, Strawsburg RH, Patterson B et al (2001) Seizure frequency and characteristics in children with Down syndrome. Brain Dev 23:375–378 ArticleCASPubMed Google Scholar